General Information
Version
1.0
Revision date
2025-06-03
Product name
Cidofovir Dihydrate
CAS No.
149394-66-1
1.2.1 Relevant identified uses
Use as laboratory reagent
Emergency telephone
+44 844 892 0111
Icons in SDS
Company Information
company name
TCI EUROPE N.V
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H341, H351, H361, H371
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Warning
Hazard statements
H315 Causes skin irritation. H341 Suspected of causing genetic defects. H351 Suspected of causing cancer. H361 Suspected of damaging fertility or the unborn child. H371 May cause damage to organs (Kidney).
Prevention
P201 Obtain special instructions before use. P260 Do not breathe dust/ fume/ gas/ mist/ vapours/ spray. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection.
Response
P308 + P311 IF exposed or concerned: Call a POISON CENTER/ doctor.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupt- ing properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commis- sion Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine dis- rupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Com- mission Regulation (EU) 2018/605 at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Skin irritation, Category 2 H315: Causes skin irritation. Germ cell mutagenicity, Category 2 H341: Suspected of causing genetic defects. Carcinogenicity, Category 2 H351: Suspected of causing cancer. Reproductive toxicity, Category 2 H361: Suspected of damaging fertility or the unborn child. Specific target organ toxicity - single expo- H371: May cause damage to organs. sure, Category 2, Kidney
